R.E.W. Hancock Laboratory: Funding Sources

Granting agency       Canadian Institutes of Health Research

Title of project          Pseudomonas aeruginosa complex adaptations

Granting agency       Canadian Institutes of Health Research

Title of project          Design and function of antimicrobial peptides

Granting agency       Cystic Fibrosis Canada

Title of project          Mechanisms of antibiotic resistance/susceptibility of Pseudomonas aeruginosa

Granting agency       Canadian Institutes of Health Research

Title of project          Novel anti-inflammatory treatment for Amyotrophic Lateral Sclerosis

Granting agency       Cystic Fibrosis Canada

Title of project          Mechanisms of hyperinflammation in cystic fibrosis

Granting agency       Cystic Fibrosis Canada (CFTI Initiative)

Title of project          IDR-1018 as an inflammatory and anti-infective treatment for CF lung infections

Granting agency       Genome British Columbia

Title of project          Vaccinomics of Animal Disease (Johne's Disease)

Granting agency       Canadian Foundation for Innovation

Title of project          Cell analysis suite for high throughput functional genomics studies

Granting agency       National Institutes of Health

Title of project          Novel adjunct therapy for drug resistant gram negative pathogens

Granting agency       Canadian Institutes of Health Research

Title of project          Chronic Childhood Vasculitis: Characterizing the individual rare diseases to improve

                                patient outcome. (Emerging Team Grant: Rare Diseases; D. Cabral PI)

Granting agency       Canadian Institutes of Health Research

Title of project          Novel antimicrobial and biofilm resistant coatings for urological and blood storage

                                devices (CHRP NSERC partnered grant; J. Kizhakkedathu PI)

Other funding:

Sponsor:                 Eli Lilly and Company in collaboration with ELANCO

Title of project         Host Defence Peptides as Novel Therapeutics